Veritas Asset Management Llp Lowers stake in UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (UNH) : Veritas Asset Management Llp reduced its stake in UnitedHealth Group Inc by 12.25% during the most recent quarter end. The investment management company now holds a total of 4,273,694 shares of UnitedHealth Group Inc which is valued at $610,625,399 after selling 596,658 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.UnitedHealth Group Inc makes up approximately 6.36% of Veritas Asset Management Llp’s portfolio.

Other Hedge Funds, Including , Courier Capital Corp sold out all of its stake in UNH during the most recent quarter. The investment firm sold 1,749 shares of UNH which is valued $249,897.Callahan Advisors reduced its stake in UNH by selling 1,376 shares or 2.18% in the most recent quarter. The Hedge Fund company now holds 61,678 shares of UNH which is valued at $8,738,539. UnitedHealth Group Inc makes up approx 2.25% of Callahan Advisors’s portfolio.Telemus Capital reduced its stake in UNH by selling 2,044 shares or 5.07% in the most recent quarter. The Hedge Fund company now holds 38,257 shares of UNH which is valued at $5,471,516. UnitedHealth Group Inc makes up approx 0.63% of Telemus Capital’s portfolio.Capital One National Association boosted its stake in UNH in the latest quarter, The investment management firm added 25 additional shares and now holds a total of 8,250 shares of UnitedHealth Group Inc which is valued at $1,179,915. UnitedHealth Group Inc makes up approx 0.09% of Capital One National Association’s portfolio.

UnitedHealth Group Inc closed down -0.17 points or -0.12% at $142.71 with 18,90,880 shares getting traded on Thursday. Post opening the session at $143.1, the shares hit an intraday low of $142.26 and an intraday high of $143.476 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, UnitedHealth Group Inc reported $1.96 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.89. The company had revenue of $46485.00 million for the quarter, compared to analysts expectations of $45039.08 million. The company’s revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.

Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .Company shares were Reiterated by Mizuho on Jul 19, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $156 .

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.

Leave a Reply

UnitedHealth Group Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on UnitedHealth Group Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.